NCT01244009 2016-11-07A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)Tesaro, Inc.Phase 2 Withdrawn
NCT00749502 2013-07-25A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)Tesaro, Inc.Phase 1 Completed113 enrolled